NASDAQ:MLTX | EBITDA | MoonLake Immunotherapeutics

Complete source-backed ebitda history.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$69.18M
2025-12-31-$64.47M
2025-03-31-$47.11M
2024-12-31-$49.22M
2024-03-31-$19.49M

Annual EBITDA

DateEBITDA
2025-12-31-$242.22M
2024-12-31-$141.71M
2023-12-31-$53.75M
2022-12-31-$64.9M